Truist Securities Adjusts Humana Price Target to $200 From $285, Maintains Hold Rating

robot
Abstract generation in progress

Truist Securities has significantly lowered its price target for Humana to $200 from $285, while retaining a “Hold” rating on the stock. This adjustment reflects a broader trend among analysts, with several other firms also reducing their price targets for Humana around the same period, citing various headwinds. Humana Inc. is a leading health insurance provider with a strong focus on government-sponsored plans and supplementary medical services.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)